Convergence Financial, LLC Johnson & Johnson Transaction History
Convergence Financial, LLC
- $471 Billion
- Q3 2024
A detailed history of Convergence Financial, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Convergence Financial, LLC holds 5,445 shares of JNJ stock, worth $871,690. This represents 0.19% of its overall portfolio holdings.
Number of Shares
5,445
Previous 7,109
23.41%
Holding current value
$871,690
Previous $1.04 Billion
15.07%
% of portfolio
0.19%
Previous 0.27%
Shares
2 transactions
Others Institutions Holding JNJ
# of Institutions
4,211Shares Held
1.7BCall Options Held
12.5MPut Options Held
10.3M-
Vanguard Group Inc Valley Forge, PA229MShares$36.7 Billion0.65% of portfolio
-
Black Rock Inc. New York, NY198MShares$31.7 Billion0.67% of portfolio
-
State Street Corp Boston, MA133MShares$21.3 Billion0.86% of portfolio
-
Geode Capital Management, LLC Boston, MA55.1MShares$8.82 Billion0.72% of portfolio
-
Morgan Stanley New York, NY42.1MShares$6.73 Billion0.48% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $419B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...